SCHEMBL7842867

SCHEMBL7842867

Cc1nc(CC(=O)Cl)c[nH]1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.31
GABRR1 P24046 1/20 0.31
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512261 0.82 GABRR1 (0.43) SMN1; SMN2GABRR1
SCHEMBL7676177 0.81 HTT (0.44) SMN1; SMN2USP2GABRR1
Hydrochloric Acid SCHEMBL1375897 0.81 GABRR1 (0.42) SMN1; SMN2GABRR1
SCHEMBL682587 0.79 USP2 (0.49) SMN1; SMN2USP2
SCHEMBL8212933 0.77 KMT2A (0.48) SMN1; SMN2
SCHEMBL6105714 0.74
Acetic Acid SCHEMBL15528121 0.73 NOTUM (0.31) SMN1; SMN2GABRR1
SCHEMBL3930088 0.73 NPSR1 (0.42) SMN1; SMN2
SCHEMBL7444234 0.73 BAZ2B (0.32)
SCHEMBL148931 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831824-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-05-02 EP disclosed
EP-0831824-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-04-01 EP disclosed
WO-1996039140-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-12-12 WO disclosed